Christopher Richard Anzalone, CEO: Arrowhead Pharmaceuticals ARWR Sell · Filed 25/03/17

Trade details

Type: Insider sale
Amount: $774,974.75
Shares · price: 51,425 sh · $15.07 a share
Held after: 4,062,377 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: Christopher Richard AnzaloneCEO
Trade date: 25/03/13
Filed: 25/03/17
Days to filing: 4 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/11~25/04/12

Christopher Richard Anzalone's recent trades

Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$488.6K
7,416 sh
$488.6K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$383.1K
5,771 sh
$383.1K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$871.7K
13,187 sh
$871.7K
Filed 01/02
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$2.4M
35,181 sh
$2.4M
Filed 25/12/30
Traded 25/12/29
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$1.1M
16,545 sh
$1.1M
Filed 25/12/30
Traded 25/12/29